SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series September class, title,number 09/09

20090240051 - New process for the production of oxabispidines: P

20090240052 - Novel anthranilic acid derivative or salt thereof: An anthranilic acid derivative represented by the general formula (X) [wherein R1 represents hydrogen or a carboxy-protecting group; R2 represents optionally substituted phenyl, a heterocyclic group, etc.; R3 represents optionally substituted phenyl, a monocyclic heterocyclic group, etc.; X1 represents carbonyl, etc.; X2 represents optionally substituted alkylene group, a bond, etc.;... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090240053 - Substituted 2-aminoacetamides and the use thereof: and to pharmaceutically acceptable salts and prodrugs thereof, wherein the substituents are defined herein. The invention is also directed to the use of substituted 2-aminoacetamides in methods for the treatment of neuronal damage following global and focal ischemia, and for the treatment, prevention or amelioration of pain, as anticonvulsants, as... Agent: Sterne, Kessler, Goldstein & Fox P.l.l.c.

20090240054 - Rosuvastatin calcium with a low salt content: Provided is rosuvastatin calcium with a low salt by product content and processes for preparing such rosuvastatin calcium.... Agent: Kenyon & Kenyon LLP

20090234116 - Ionic liquids: The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification,... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090234117 - Pyrazolopyrimidine derivative: e

20090234118 - Ionic liquids: The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification,... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090234119 - Ionic liquids: The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification,... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090234120 - Ionic liquids: The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification,... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090227789 - Ethylenediamine derivatives: P

20090227790 - Neuroprotective small organic molecules, compositions and uses of related thereto: The present application is directed to therapeutic compounds, compositions, and methods for culturing neuronal cells and for preventing and the treatment of neurodegenerative diseases, such as Parkinson's disease and amyotrophic lateral sclerosis (ALS).... Agent: Leu-fen H. Lin

20090227791 - Active esters of n-substituted piperazine acetic acids, including isotopically enriched versions thereof: In some embodiments, this invention pertains to active esters of N-substituted piperazine acetic acid, including isotopically enriched versions thereof. In some embodiments, this invention pertains to methods for the preparation of active esters of N-substituted piperazine acetic acid, including isotopically enriched versions thereof.... Agent: Mila Kasan, Patent Dept. Applied Biosystems

20090227792 - Highly reactive a-aminomethyl-alkoxysilanes having improved stability: α-aminoalkoxysilanes wherein the α-amino group is a tertiary amino group, and which also contains a further reactive group, display excellent reactivity of the alkoxy groups while remaining stable with respect to decomposition and byproduct formation, particularly through cleavage of the Si-C bond. The α-aminosilanes are particularly useful for preparing alkoxysilyl-terminated... Agent: Brooks Kushman P.C.

20090227793 - Image-forming material: The image-forming material includes a perimidine-based squarylium dye represented by the following formula (I):... Agent: Sughrue-265550

20090227794 - Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione: The instant invention provides crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione; processes for the production of such crystalline materials; pharmaceutical compositions comprising such crystalline materials; and methods of treating HIV or AIDS with such crystalline materials or such pharmaceutical compositions.... Agent: Louis J. Wille Bristol-myers Squibb Company

20090227795 - Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereof: e

20090221816 - Process for the asymmetric epoxidation of olefins: The present invention relates to a catalyst based on ruthenium complexes and to a process for the asymmetric epoxidation of olefins using catalysts based on ruthenium complexes.... Agent: Lanxess Corporation

20090221817 - Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives: e

20090221819 - Fluorescent compounds and use of said compounds in multiphoton methods or devices: The invention relates to a chemical compound with an effective double photon absorbance section of greater than 50 GM, preferably greater than 100 GM, for at least one wavelength in the range 700-1200 nm, characterised in being made up of a core with double photon absorption properties connected by separate... Agent: Thomas, Kayden, Horstemeyer & Risley, LLP

20090221818 - Inhibitors of fibroblast activation protein alpha: Disclosed are peptide-based compounds that include boronic acid or cyano functionality, which efficiently and selectively inhibit fibroblast activation protein alpha. Among other therapeutic utilities, the peptide-based compounds may be useful for the treatment of cancer.... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20090221820 - Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof: Ligands for transition metals are disclosed herein, which may be used in various transition-metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions. The disclosed methods provide improvements in many features of the transition-metal-catalyzed reactions, including the range of suitable substrates, number of catalyst turnovers, reaction conditions, and efficiency. For example, improvements have been... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20090221821 - Adenosine receptor antagonists and methods of making and using the same: g

20090221822 - Process for the preparation of dihydroquinazolines: The present invention relates to a process for the preparation of dihydroquinazolines, which are used for the production of medicaments.... Agent: Barbara A. Shimei Director, Patents & Licensing

20090221823 - Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates: The present invention is related to 1-[(4-chlorophenyl)-phenylmethyl]-4-(2,2,2-trichloroethoxycarbonyl)-piperazine of the Formula (IV) and optically isomers thereof, process for preparation thereof and the use of the compound of the Formula (IV) in the preparation of 1-(4-chlorophenyl)-phenylmethyl-piperazine and optical isomers and salts thereof. 1-(4-chlorophenyl)-phenylmethyl-piperazine and optical isomers thereof are important intermediates in the... Agent: K.f. Ross P.C.

20090221824 - Enantioselective process: A process for the production of compounds comprising the enantioselective hydrogenation of 2-substituted acrylic acid derivatives.... Agent: Eli Lilly & Company